RedHill Biopharma (RDHL) Exchange Rate Effect (2016 - 2022)
RedHill Biopharma has reported Exchange Rate Effect over the past 11 years, most recently at -$16000.0 for Q4 2022.
- Quarterly Exchange Rate Effect fell 277.78% to -$16000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was -$76000.0 through Dec 2022, up 21.65% year-over-year, with the annual reading at -$2000.0 for FY2025, 122.22% down from the prior year.
- Exchange Rate Effect was -$16000.0 for Q4 2022 at RedHill Biopharma, down from -$13000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $131000.0 in Q1 2020 and troughed at -$103000.0 in Q1 2021.
- The 5-year median for Exchange Rate Effect is -$13500.0 (2018), against an average of -$2650.0.
- The largest YoY upside for Exchange Rate Effect was 718.75% in 2020 against a maximum downside of 3400.0% in 2020.
- A 5-year view of Exchange Rate Effect shows it stood at -$16000.0 in 2018, then soared by 437.5% to $54000.0 in 2019, then plummeted by 83.33% to $9000.0 in 2020, then changed by 0.0% to $9000.0 in 2021, then crashed by 277.78% to -$16000.0 in 2022.
- Per Business Quant, the three most recent readings for RDHL's Exchange Rate Effect are -$16000.0 (Q4 2022), -$13000.0 (Q3 2022), and -$32000.0 (Q2 2022).